Interferon-γ decreases ceramides with long-chain fatty acids: Possible involvement in atopic dermatitis and psoriasis

Journal of Investigative Dermatology

Volumn 134, Issue 3, 2014, Pages 712-718

  Tawada, Chisato ^a   Kanoh, Hiroyuki ^a   Nakamura, Mitsuhiro ^b   Mizutani, Yoko ^a   Fujisawa, Tomomi ^a   Banno, Yoshiko ^a   Seishima, Mariko ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CERAMIDE DERIVATIVE; CERAMIDE SYNTHASE; ELONGASE OF LONG CHAIN FATTY ACID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LONG CHAIN FATTY ACID; MESSENGER RNA; STAT1 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CERAMIDE; CERAMIDE SYNTHASE 1; CERAMIDE SYNTHASE 2; CERAMIDE SYNTHASE 3; CERAMIDE SYNTHASE 4; CERAMIDE SYNTHASE 5; CERAMIDE SYNTHASE 6; ELONGASE OF LONG CHAIN FATTY ACID 1; ELONGASE OF LONG CHAIN FATTY ACID 2; ELONGASE OF LONG CHAIN FATTY ACID 3; ELONGASE OF LONG CHAIN FATTY ACID 4; ELONGASE OF LONG CHAIN FATTY ACID 5; ELONGASE OF LONG CHAIN FATTY ACID 6; ELONGASE OF LONG CHAIN FATTY ACID 7; ENZYME; INTERLEUKIN 17; SMALL INTERFERING RNA; STAT3 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SIZE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; VERY ELDERLY; YOUNG ADULT; CELL CULTURE; CONCENTRATION RESPONSE; EPIDERMIS CELL; GENE EXPRESSION; GENE SILENCING; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CERAMIDES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EPIDERMIS; FATTY ACIDS; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA; KERATINOCYTES; MALE; MIDDLE AGED; PSORIASIS; YOUNG ADULT;

EID: 84894030033     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.364     Document Type: Article

References (41)

1. Barker JN, Karabin GD, Stoof TJ et al. (1991) Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci 2:106-111
2. Bieber T (2010) Atopic dermatitis. Ann Dermatol 22:125-377
3. Cho Y, Lew BL, Seong K et al. (2004) An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J Korean Med Sci 19:859-633
4. Choi MJ, Maibach HI (2005) Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 6:215-233
5. Cameron DJ, Tong Z, Yang Z et al. (2007) Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci 3:111-99
6. Del Prete G (1992) Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 47:450-55
7. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-500
8. Di Nardo A, Wertz P, Giannetti A et al. (1998) Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78:27-300
9. Feingold KR (2007) The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531-466
10. Gough DJ, Levy DE, Johnstone RW et al. (2008) IFNgamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev 19:383-944
11. Grewe M, Gyufko K, Schopf E et al. (1994) Lesional expression of interferongamma in atopic eczema. Lancet 343:25-66
12. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359-611
13. Gudjonsson JE, Ding J, Johnston A et al. (2010) Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 130:1829-400
14. Guillou H, Zadravec D, Martin PG et al. (2010) The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res 49:186-999
15. Imokawa G, Abe A, Jin K et al. (1991) Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 96:523-66
16. Ishikawa J, Narita H, Kondo N et al. (2010) Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 130:2511-44
17. Jakobsson A, Westerberg R, Jacobsson A et al. (2006) Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 45:237-499
18. Janu B, Zbytovská J, Lorenc P et al. (2011) Effect of ceramide acyl chain length on skin permeability and thermotropic phase behavior of model stratum corneum lipid membranes. Biochim Biophys Acta 1811:129-377
19. Jennemann R, Rabionet M, Gorgas K et al. (2012) Loss of ceramide synthase 33 causes lethal skin barrier disruption. Hum Mol Genet 21:586-6088
20. Joo KM, Nam GW, Park SY et al. (2010) Relationship between cutaneous barrier function and ceramide species in human stratum corneum. J Dermatol Sci 60:47-500
21. Li W, Sandhoff R, Kono M et al. (2007) Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int J Biol Sci 3:120-88
22. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-111
23. Masukawa Y, Narita H, Shimizu E et al. (2008) Characterization of overall ceramide species in human stratum corneum. J Lipid Res 49:1466-766
24. Masukawa Y, Narita H, Sato H et al. (2009) Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res 50:1708-199
25. Mizutani Y, Kihara A, Chiba H et al. (2008) 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J Lipid Res 49:2356-644
26. Mizutani Y, Mitsutake S, Tsuji K et al. (2009) Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 91:784-900
27. Motta S, Monti M, Sesana S et al. (1993) Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1182:147-511
28. Motta S, Monti M, Sesana S et al. (1994) Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol 130:452-66
29. Nemoto S, Nakamura M, Osawa Y et al. (2009) Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J Biol Chem 284: 10422-322
30. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-5099
31. Ohno Y, Suto S, Yamanaka M et al. (2010) ELOVL1 production of C24 acyl- CoAs is linked to C24 sphingolipid synthesis. Proc Natl Acad Sci USA 107:18439-444
32. Park YH, Jang WH, Seo JA et al. (2012) Decrease of ceramides with very longchain fatty acids and downregulation of elongases in a murine atopic dermatitis model. J Invest Dermatol 132:476-99
33. Pewzner-Jung Y, Ben-Dor S, Futerman AH et al. (2006) When do Lasses (longevity assurance genes) become CerS (ceramide synthases): insights into the regulation of ceramide synthesis. J Biol Chem 35:25001-55
34. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375-866
35. Rabionet M, van der Spoel AC, Chuang CC et al. (2008) Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide synthase-3. J Biol Chem 19:13357-699
36. Ramana CV, Gil MP, Han Y et al. (2001) Stat1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 98: 6674-99
37. Sassa T, Ohno Y, Suzuki S et al. (2013) Impaired epidermal permeability barrier in mice lacking Elovl1, the gene responsible for very-long-chain fatty acid production. Mol Cell Biol 33:2787-966
38. Szabo SK, Hammerberg C, Yoshida Y et al. (1998) Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4-and CD8-subsets. J Invset Dermatol 111:1072-88
39. Uchida Y. (2011) The role of fatty acid elongation in epidermal structure and function. Dermatoendocrinol 3:65-99
40. Vasireddy V, Uchida Y, Salem N Jr et al. (2007) Loss of functional ELOVL44 depletes very long-chain fatty acids (4-28) and the unique omega-Oacylceramides in skin leading to neonatal death. Hum Mol Genet 16: 471-822
41. Wolf R, Orion E, Ruocco E et al. (2012) Abnormal epidermal barrier in the pathogenesis of psoriasis. Clin Dermatol 30:323-88